However, several investigators have reported encouraging results of hypofractionated techniques for prostate cancer. More recently, some institutions have used SBRT as a boost after external beam ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which patients with prostate cancer are at higher risk of developing long-lasting ...

For the new study, researchers set out to confirm that PROSTOX works in a new group of 148 patients who’d received stereotactic body radiotherapy (SBRT) for their prostate cancer. SBRT is a ...

HealthDay News — A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is valid for predicting radiotherapy (RT)-induced genitourinary (GU) toxicity in patients ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer, van As et al, N Engl J Med 2024;391:1413-1425 ** SBRT (Stereotactic Body Radiation Therapy) involves treatment in ...

But a new genetic test appears capable of sussing out which men are at greater risk of urinary side effects from radiation ...

versus computed tomography-guided prostate stereotactic body radiotherapy (SBRT). The researchers found that PROSTOX predicted late GU toxicity accurately, yielding an area under the curve (AUC ...